| | 755037-03-7 Basic information More.. |
| Product Name: | Regorafenib | | Synonyms: | 4-[4-({[4-chioro-3-(trifluoroMethyl)phenyl]carbaMoyl}aMino)-3-fluorophenoxy]-pyridine-2-carboxylic acid MethylaMide;REGORAFENIB BAY 73-4506 BAYER HEALTHCARE (SEE ALSO COLORECTAL, LUNG, STOMACH) PHASE II(REGORAFENIB) PHARMACEUTICALS (888) 842-2937WAYNE, NJ;4-[4-[[[[4-Chloro-3-(trifluoroMethyl)phenyl]aMino]carbonyl]aMino]-3-fluorophenoxy]-N-Methyl-2-pyridinecarboxaMide;4-[4-[N'-(4-Chloro-3-trifluoroMethylphenyl)ureido]-3-
fluorophenoxy]pyridine-2-carboxylic Acid MethylaMide;regorafinib;Regafenib;Reggae sorafenib;Regorafenib C3X-1410 | | CAS: | 755037-03-7 | | MF: | C21H15ClF4N4O3 | | MW: | 482.82 | | EINECS: | 815-051-1 | | Mol File: | 755037-03-7.mol |  |
Use
Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively
- Regorafenib
-
- US $100.00-80.00 / KG
- 2024-09-29
- CAS:755037-03-7
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 10000kg
- Regorafenib
-
- US $0.00 / g
- 2024-09-29
- CAS:755037-03-7
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
- Regorafenib
-
- US $0.00-0.00 / kg
- 2024-09-27
- CAS:755037-03-7
- Min. Order: 1kg
- Purity: 99%, Single impurity＜0.1
- Supply Ability: 1 ton
|
|
755037-03-7
Recommend Suppliers |
|